On January 12, Baiyunshan, a listed company of GPHL, announced a plan for private placement. The plan quickly became the focus of the industry: On January 13, Baiyunshan A shares were closed at a daily limit of 10%, Baiyunshan Hong Kong stocks Then it rose by 18.8%. What is special about the fixed-income case of GP, which is so optimistic about the market?
First of all, the amount of the increase in the amount of pharmacopoeia is 10 billion yuan, which has set the largest scale for the private placement of A-share pharmaceutical industry. Secondly, Shanghai Yunfeng Xinchuang Investment Management Co., Ltd. is listed as a subscription seat of 500 million yuan. The industry knows that Ma Yun is the big BOSS that is worthy of attention behind Yunfeng. This is another new generation of Ma Yun’s medical layout after CITIC 21. The imagination is very large. Finally, the employee stock ownership plan implemented by the simultaneous increase of the case is caused. The market is highly concerned, and the number of participating employees is expected to become a new sample of the reform of state-owned enterprises in Guangzhou.
[The king of the increase]
Let’s first look at the record increase in this amount:
According to the announcement, according to the plan, the total number of non-public issuance of A shares will not exceed 41,946,100 shares, and the issue price will be 23.84 yuan per share. The total amount of funds raised will not exceed 10 billion yuan.
The proposed investment projects include “Da Nan Pharmaceuticalâ€, “Big Commercialâ€, “Great Healthâ€, “Information Platform Construction Project†and supplementary liquidity. Among them, “Da Nan Pharmaceutical†is divided into two research and development platforms and production bases. The amount of funds raised is 1.5 billion yuan and 1 billion yuan respectively, accounting for 100% and 54.9% of the total investment of 1.5 billion and 1.82 billion respectively. The “Big Commercial†project refers to the capital increase of Guangzhou Pharmaceutical Co., Ltd. The total investment and fundraising amount are both 1 billion yuan. The specific content is intended to invest in external expansion mergers and acquisitions, modern pharmaceutical logistics extension service system construction and build a pharmaceutical e-commerce platform. The “Great Health†business section is the focus of the capital increase and use plan since then, and 4 billion yuan will be increased to Guangzhou Wang Lao Ji Da Health Industry Co., Ltd. The information platform construction project will have a total investment of 200 million yuan, and the remaining 2.3 billion yuan will supplement the working capital.
How about 10 billion? To put it simply, Baiyunshan will use 4 billion to “subsidize†Wang Laoji (this is the main event), 2.5 billion for R&D and production, 1 billion for business, 2.3 billion for supplementary liquidity, and 200 million for information. Construction.
[Ma Yun medicine layout moves]
What are the objects of the fixed release? The controlling shareholder of the company, GP Group, Tianfu-Dingsheng Shengshi Special Account No. 66 Asset Management Plan, Guangzhou State-owned Development Holdings Co., Ltd., Guangzhou Guoshou Urban Development Industrial Investment Enterprise (Limited Partnership), Shanghai Yunfeng Xinchuang Investment Management Co., Ltd. There are 5 specific targets, such as the special investment subject to be established. They are all subscribed in cash. The subscription amounts are about 3.495 billion yuan, 505 million yuan, 3 billion yuan, 2.5 billion yuan, and 500 million yuan. The subscription period is 36 months.
“Is the special investment subject to be established by Shanghai Yunfeng Xinchuang Investment Management Co., Ltd.†Is it a bit too much? Ma Yunjia, is it simple and clear? Shanghai Yunfeng Xinchuang Investment Management Co., Ltd. was established in May 2014. One of the shareholders is Ma Yun, the legal representative is Qi Feng, who was the president and founder of Shanghai Juzhong Target Media Co., Ltd.
According to public information, in the first half of 2014, Yunfeng Fund raised $1.1 billion and completed the creation of a new investment fund that will focus on TMT, consumer and healthcare .
Facebook reminds you of a recent investment case: Yunfeng Fund teamed up with Alibaba in January 2014 to invest in CITIC 21st Century with a total of US$170 million (approximately RMB 1.037 billion). 54.3% of the shares. In October of the same year, the company changed its name to “Ali Health†and then cooperated with chain pharmacies to build the O2O platform.
Is it a familiar story? Does Ma Yun’s medical dream have to use the Guangyao fixed investment case to have further pieces? Is this a financial investment or a strategic investment? There are many imaginations in the industry.
Sure enough, according to the news released on the spot of the January 13th Pharmacy Supplement, the site: Guangyao Baiyunshan and Ali Health signed a strategic cooperation intention, which will be in the three majors of pharmaceutical e-commerce, medical health services and big health industry. Cooperation in the field.
[Employee incentive program involving 4883 people]
In the fixed-increasing plan, the trustee of the Tianfu-Dingshengshengshi special account No. 66 asset management plan is the Baiyunshan 2015 employee stock ownership plan, which includes some directors, supervisors and senior managers of the company. The employees of the company, subordinate enterprises and affiliated companies subscribed.
It is understood that according to the plan, the total number of employees participating in the employee stock ownership plan is 4,883, and the total share of the participants in the shareholding plan is no more than 42,378, and the amount is 11,920 yuan, the total amount is not More than 505 million yuan. Among them, the directors (excluding independent directors), supervisors and senior management personnel who participated in the employee stock ownership plan were 11 persons, and the total subscription amount was no more than 3,680, and the proportion of their subscription shares to the total share of the employee stock ownership plan was 8.68. %.
In 2013, Guangzhou Pharmaceutical Baiyunshan achieved an overall listing, and the employee stock ownership plan has been receiving attention. Some insiders believe that in the context of the reform of state-owned enterprises, through the rational refinancing arrangements, the implementation of employee stock ownership plans, the establishment of a reasonable incentive and restraint mechanism, help to achieve the common growth of employees and enterprises, Guangyao Baiyunshan this time The public offering has made active and effective explorations in the reform of the seniorized mixed ownership system in Guangzhou.
What is the pet scanner?
[Pet Scanner] involves high-tech innovation projects of medicine, bio-informatics, electrical engineering and other sciences. Using the quantum medicine as the theoretical basis, it applies the advanced electronic equipment to collect the weak magnetic field of animal cells for scientific analysis, thereby analyzing and determining the tested animal's health status and main problems and
putting forward standard prevention recommendations. [Pet scanner] is individualized guide of health care consultation for full animal body and forward health science, and has the advantages of completeness, non-invasiveness, practicality, simplicity, fastness, economy, easy popularization, etc. With the depth and development of scientific research, it will make a greater contribution for the cause of animal health, having a broad development and application prospect.
Principle of quantum analyzer:
The animal body is the aggregates of a large number of cells which are in continuous growth, development, differentiation, regeneration and apoptosis, and the cells constantly self-renew through its own division. In the process of cell division and growth, those charged bodies of atomic nucleuses constituting atoms as the basic unit of cell and the electrons outside the nucleus are in constant high-speed movement and changing, thereby constantly emitting electromagnetic waves.
The electromagnetic wave signals emitted by the animal body represent the specific state of the animal body, and the emitted electromagnetic wave signals are different under the different conditions of the human body, such as health, sub-health, disease, etc. If we can determine these specific electromagnetic wave signals, we can determine the status of the body's life.
Quantum medicine considers that the most fundamental reason of falling sick is that the spin of electrons outside the atomic nucleus and the orbit change, thereby causing the change of atoms constituting a material, the change of small biomolecules, the change of big biomolecules, the change of all the cells and finally the change of organs. Because the electron is a charged body,
when the spin of electrons outside the atomic nucleus and the orbit change, the electromagnetic wave emitted by the atoms will change. The energy o f the electromagnetic wave changes caused by the changes of the animal body's diseases and physical changes in the nutritional status is extremely weak and usually is only nano gauss to microgauss. The frequency and energy of the
weak magnetic field of hair determined directly or by holding a sensor compare with the resonance spectra of standard quantum of diseases and nutrition indicators set in the instrument after the frequency and energy are amplified by the instrument and processed by the computer, and then the corresponding quantum value being from negative to positive is output. The size of the
quantum value indicates the nature and extent of the disease and the nutrition levels. Finally, the test results are resolved by clinicians. It's similar to the principle of listening to broadcasting from the radio. There are many radio waves in the air. If you want to listen to some designated broadcasting, you can transfer the radio to the corresponding frequency, at this moment, resonance occurs, so that you can listen to this broadcasting. Quantum resonance uses this principle for testing.
Animal Quantum Analyzer, Dog Quantum, Cat Quantum
Shenzhen Guangyang Zhongkang Technology Co., Ltd. , https://www.szlighttherapymachine.com